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Background: The availability of glucose in tissue has a role in macrophages 
polarization into an inflammatory phenotype. The over nutrition condition such as 
hyperglycemia induces macrophage infiltration especially the inflammatory 
macrophages. The aim of this study is to analyse the effect of hyperglycemia condition 
on cytokines production by human monocytes-derived macrophages.  
Materials and methods: Monocyte cells that obtained from peripheral blood 
mononuclear cells isolation from donors were incubated for 6 days in 37°C, 5% CO2. 
On day 4, the stimulating factors such as lipopolysaccharide (LPS) and interferon 
(INF)-ɤ were added to activate monocytes into macrophages. Then on day 6, two doses 
of glucose; either normal or high doses along with low or high dose of LPS were given 
for 24 hours, followed by collecting the culture media and cells then stored at −80°C 
until assayed.  
Results: There was significantly different of TNF-α level among groups, with highest 
level found in group with high dose glucose plus high dose LPS. However, the 
concentration of IL-6 among groups was not significantly different.  
Conclusions: Macrophages treated with high dose glucose plus high dose LPS 
significantly increased TNF-α production, but not for IL-6. 
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Macrophage is part of innate immune cells that responds immediately to any 
invaders or cell debris. Macrophages have pathogen recognition receptors (PRRs) on its 
surface that can recognize pathogen associated molecular patterns (PAMPs) or 
endogenous danger associated molecular patterns (DAMPs) [1]. To bind to those 
molecules, macrophages equipped with toll like receptors (TLR). NOD like-receptors 
(NLRs), the HIN-200 receptor family, and RIG-1-like receptor (RIRs) are also types of 
PRRs that can be found in macrophages which located in the cytoplasm and act as 
stressor signals when pathogen found in the cytoplasm [2]. 
Macrophages also have role to maintain tissue homeostasis [3], by polarizing 
into two types subpopulations, depend on the microenvironment they exposed to [4]. 
The classical or proinflammatory macrophages, known as M1 and the alternative or 
anti-inflammatory macrophages as M2 [5]. The imbalance of the M1/M2 ratio occurs in 
chronic inflammation condition such as insulin resistance, cardiovascular disease,  
obesity, tumor development, and autoimmune disease [5]. 
Macrophages infiltration also increases in the metabolic active tissue during over 
nutrition condition that lead to proinflammatory environment and marked by the 
increased of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and inducible nitric 
oxide synthase (iNOs) secretion. In type 2 diabetes mellitus, macrophages involve in 
progressivity of the disease by altering metabolic pattern [6]. In obese patients, the M1 
macrophages infiltrate the enlarged fat cells of adipose tissue and results in production 
abundance of inflammatory cytokines such as TNF-α and IL-6. These contribute to the 
decrease of insulin sensitivity and the ability of glucose uptake in fat cells [2]. 
 In the presence of interferon (IFN)-γ and lipopolisaccharide (LPS), macrophage 
will rapidly activate their glycolytic pathway. Then, the abundance of glucose uptake 
and utilization lead to the increases of IL-6 and IL-1β secretion. Hence, the availability 
of glucose in a tissue may shift macrophages polarization into an inflammatory 
phenotype [3]. In diabetes, the M1 macrophages persistently lead to diabetic neuropathy 
by over production of protease, cytokines and reactive oxygen species (ROS). These 
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molecules induce oxidative stress and degradate myelin and damage neuron 
regenerative. M1 macrophages may also change pancreas cells functions and cause 
insulin resistance [7]. The M1 proinflammatory macrophages may produce, release and 
respond to cytokines and chemokines in its environment such as TNF-α, IL-6, IL-1, and 
monocyte chemoattractant protein [MCP]-1. On the other hand, if the environments do 
not need the dominancy of proinflammatory macrophages, they adapt to the M2 
macrophages. The anti-inflammatory macrophages, M2 then allow the resolution of 
inflammation. The anti inflammatory cytokines and the growth factors that released by 
M2 such as the antagonist receptor IL-1, IL-10, and transforming growth factor [TGF]-
β, induce the decrease of the pro-inflammatory factors and then reduce the macrophages 
activation. The diminish of macrophages activation marked the end of acute 
inflammation. But, if the process is hampered, the resolution of inflammation can not be 
achieved and chronic inflammation occurs [8]. 
The hyperglycemic condition may activate monocyte, and increase the 
expression of pro inflammatory macrophages (M1 pheotype), even if there is no tissue 
damage or infection [8]. Previous study showed that hyperglycemic mice induced by 
streptozotocin had vast infiltration of macrophages and developed into a systemic 
proinflammatory state shown by the increase of IL-6, IL-1b, TNF-α, and IL-8 [9]. An in 
vitro study on human monocytes and macrophages that exposed to high levels of 
glucose also underwent into inflammatory macrophages and the same situation 
apparently also being observed in patients with hyperglycemia [10]. 
The aim of the study was to analyse the effect of hyperglicemia condition in the 
environment of the macrophage cell culture. 
 
MATERIAL AND METHODS 
Subject recruitment 
The blood donors for this study were from three females and one male with age 
average 20 years old, body weight 64.5 ± 8.44 kg, height 161.5 ± 1.66 cm, and body 
mass index (BMI) 25.20 ± 3.30 kg/m2. All participants were screened for eligible 
criteria, such as not having any infection and metabolic diseases in one month before 
and also signed the informed consent after being explained about the study procedures. 
All procedures of this study were approved by the Ethical Committee of Human 
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Studies, Faculty of Medicine and Adam Malik General Hospital, Medan. This study was 
conducted in the Research Laboratory of Faculty of Medicine, Universitas Sumatera 
Utara, Medan, Indonesia between July and October 2019. 
 
Isolation of peripheral blood mononuclear cells (PBMCs) 
Fifty millilitres of blood was withdrawn from venous and collected in EDTA 
contained vacutainer tubes. The PBMCs of buffy coat were collected by gradient 
centrifugation using LymphoprepTM (Stemcell, Axis-Shield, Dundee, UK), according to 
the manufacturer’s instruction.    
 
Isolation of monocytes 
Monocytes were isolated from PBMCs by using EasySepTM negative monocyte 
isolation kit (StemcellTM Technologies, Vancouver, Canada). Briefly, the PBMCs were 
treated with antibody and platelet removal before selected with magnet beads and 
incubate in an EasySep Magnet (StemcellTM Technologies, Vancouver, Canada) 
according to the manufacture’s procedures. 
 
Culture of monocytes 
Monocytes were cultured in RPMI 1640 (Gibco, Waltham, MA, USA) 
supplemented with with 10% foetal bovine serum, FBS (Sigma, St Louis, MO, USA), 
1% penicillin-streptomycin (Gibco, Waltham, MA, USA) and 1% L-glutamine (Gibco, 
Waltham, MA, USA) at 37°C in a 5% CO2 humidified incubator. Recombinant human 
M-CSF/CSF1 (ABclonal Technology, Woburn, MA, USA) at the concentration of 50 
ng/mL was used to direct macrophage differentiation. Cells were incubated for 6 day in 
37°C, 5% CO2. The monocytes seeded in 24 wells culture plates (Iwaki tissue culture 
treated polystyrene microplate, Asahi Glass Co., Japan). On day 4, fresh media were 
added with Lipopolysachharide, LPS (10 ng/ml) from E. coli (O26:B6) (Sigma, St 
Louis, MO, USA) and IFN-γ (50 ng/ml) (StemcellTM Technologies, Vancouver, 
Canada) to differentiate macrophage into M1 macrophages. On day 6, all media were 





The macrophages were divided into five groups, two were supplemented with 
two doses of glucose (Sigma, St Louis, MO, USA) (7 mM as normal dose, ND-Glu, and 
35 mM as high dose, HD-Glu). This concentration is based on the diabetes diagnosis by 
WHO (11) and doubling the dosage will resemble the diabetes state in patients (8). The 
other three groups beside having the two doses of glucose also supplemented with LPS 
(low dose 100 ng/ml, LD-LPS and high doses 2 µg/ml, HD-LPS). The control group 
was treated with serum-free complete media. The treatments were given for 24 hours 




The coverslips that previously put inside the wells were discarded and left dry in 
room temperature. Then fixed with 98% methanol for 1 min and bathed with Giemsa 
(diluted with distilled water, 1:1 vol/vol) for 5 min. The final step, the coverslips were 
washed with distilled water and left to dry then mounted onto slides. The Giemsa 
staining of macrophages stimulated with normal dose of glucose is seen in Figure 1 and 
2 and in high dose of glucose in Figure 3 and 4, with 10x10 and 10x40 magnification. 
 
Analysis of cytokines production 
Human Pico Kine ELISA kits (My BioSource Inc., San Diego, CA, USA) were 
used to analyse the concentration of TNF-α and IL-6 according to manufacturer’s 
protocols. The assays were performed in duplicate. The intra assay coefficient of 
variations were < 11%. 
 
Statistical analysis 
All data are presented as mean ± standard deviation. All data were normally 
distributed after analysed using Shapiro Wilk test, then were analysed with one way 
ANNOVA and followed by Bonferroni post hoc test. The p value < 0.05 was considered 






The production of TNF-α 
Test of variances homogeneity with Leven test showed that there is significant 
differences in variance with p value = 0.001, then one way ANOVA Welch test showed 
that the data is significantly different among groups with p value = 0.004 (p value < 
0.05). The Robust Test of Equality of Means showed the p value = 0.29 (p value >0.05) 
(equals variances assumed), so the analysis was continued with the post hoc test 
Bonferroni to find which groups are significantly different. 
As can be seen in Tabel 1, the level of TNF-α were significantly different among 
groups with p = 0.004, group treated with normal dose of glucose had lowest TNF-α 
concentration (40.67 ± 9.94 pg/mL), while in group treated with high dose of glucose 
plus high dose of LPS had highest TNF-α concentration (2150.22 ±1379.77 pg/mL).  
This study showed that macrophages treated with normal dose or high dose of 
glucose and/or stimulated with low dose or high dose of LPS had higher concentration 
of TNF-α compared to the treated macrophages. Then, after being analysed with the 
Bonferroni post hoc test, it was shown that there are significantly differences of TNF-α 
concentration within groups; Control vs HD-Glu+HD-LPS (mean differences (MD) = 
−2107.34 pg/mL; p value = 0.015), ND-Glu vs HD-Glu+HD-LPS (MD = −1943.53 
pg/mL; p value = 0.009), and HD-Glu vs HD-Glu+HD-LPS (MD= −2095.69 pg/mL, p 
value = 0.002). It means that high dose of glucose plus high dose of LPS resulted in an 
increase of TNF-α production (Table 2). 
 
The production of IL-6 
This study showed that the lowest concentration of IL-6 were found in group 
treated with high dose of glucose (43.37 ± 16.29 pg/mL), meanwhile the highest 
concentration was found in group with high dose of glucose plus high dose of LPS 
(59.66 ± 16.72 pg/mL). But after being analysed with one way ANOVA test, the 
concentrations of IL-6 were not significantly different (p value=0.742). see Table 3. 
 
The macrophages staining 
This study also performed the Giemsa staining of macrophages with normal 
dose and high dose glucose. The figures are shown with 10x10 and 10x40 





We observed that the highest level of TNF-α was found in the HD-Glu + HD-
LPS group, and the lowest was found in control group (p value = 0.004). This finding is 
similar to previous study that compared the production of proinflammatory cytokines in 
macrophages that stimulated with LPS to the non-stimulated macrophages. The 
previous study showed that the production of TNF-α, MCP-1, IL-6 and IL-1β were 
significantly higher in stimulated macrophages compared to control [7]. Previous study 
also showed that THP-1 macrophage cultured in high glucose concentration (15mM) 
with or without LPS stimulation displayed higher concentration of TNF-α compared to 
normal glucose (5 mM) or osmotic control group [8]. Furthermore, activated 
macrophages that stimulated with hyperglycemia and hypoxia condition were shown to 
upregulate TNF-α, IL-6 and IL-1 gene expression [11]. Another study on diabetic rats 
induced by streptozotocin also shown an increase of TNF-α and overexpression of 
inflammatory genes, such as TNF-α, COX-2 and iNOS [12]. 
Differences of TNF-α concentration was observed among groups; Control vs 
HD-Glu+HD-LPS, ND-Glu Vs HD-Glu+HD-LPS, and HD-Glu vs HD-Glu+HD-LPS 
with each p value were 0.015, 0.009, and 0.002 (p value<0.05), respectively. The 
macrophages with high dose glucose plus high dose LPS were significantly produce 
higher TNF-α compared to the serum free medium (control), or to the macrophages with 
normal or high dose glucose.  
The tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), or the 
recognition of LPS are the Th1 (T helper 1) cytokines that can trigger the polarization of 
proinflammatory M1 macrophages. The activity of these M1 macrophages will then 
increase the expression of IL-12, IL-23, and the production of TNF, IL-1β and IL-6, and 
also the reactive oxygen species (ROS) via activation of NADPH oxidase system. The 
function of this action is to remove pathogen during infection that results in ROS-
mediated tissue damage and decline wound healing [13]. It also has been known that the 
circulating LPS bind with LPS binding protein (LBP) and caught by CD14 surface 
scavenging receptor. This signal activates TLR that initiates the phosphorylation 
cascade mediated by different kinase enzymes. The result of this signal is releasing 
transcription factor NFκB from its inhibitor IκB and translocate to the nucleus. The 
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effect of this cascade is increasing the expression of inflammatory genes such as TNF, 
antibiotic peptides and NADPH oxidase that produce the reactive oxygen intermediate 
[14].  
We observed that the highest level of IL-6 was found in HD-Glu + HD-LPS and 
the lowest was found in HD-Glu, but the differences were not significant (p value > 
0.05). This study showed that the IL-6 production was not changed by glucose and/or 
LPS stimulation. This result is in contrary to previous study that analysed the 
differences in cytokine production among type 2 diabetes patients and Diabetic 
Periperal Neuropathy (DPN) patients, the macrophages from patients with type 2 
diabetes had significantly produce higher level of IL-6 when compared to control and 
DPN patients [7]. Another study also showed that THP-1 macrophagges produced 
higher level of IL-6 when stimulated with high glucose and LPS, in compare to control 
group. The concentration of normal glucose in that study was 5mM and the high 
glucose was 15mM [8]. It means that M1 macrophages are more metabolically active in 
hyperglycaemic conditions, and promote obesity associated insulin resistance [15]. The 
different of this finding to those studies is the dose being used. In addition, the 
dramatically increased of the IL-6 gene expression was seen after 17 hours activation 
and stimulated with hyperglycemic along with hypoxia [11], meanwhile in this study 
the concentration of IL-6 was analysed after 24 hours stimulated. Similar results also 
found in the previous study of monocytes-derived macrophages exposed to high glucose 
(15mM) that showed no significant differences of TNF-α production when compared to 
the normal glucose (5mM) or hyperosmotic (glucose free) conditions [10].  
The limitation of this study is we did not perform the immunophenotypic 
assessment that is useful to identify and count the percentage of cells. Anyhow, we 




Finally, this study concluded that macrophages which stimulated with high dose 
of glucose plus high dose of LPS significantly increased the TNF-α production. On the 
other hand, different dosages of glucose and LPS stimulation to the macrophages cell 
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Table 1. The TNF-α level among groups 
Groups TNF-α (pg/mL) p value 
Control 42.88 ± 22.85 0.004* 
ND-Glu 40.67 ± 9.94  
HD-Glu 54.43 ± 26.93  
ND-Glu+HD-LPS 915.09 ± 804.02  
HD-Glu+LD-LPS 979.49 ± 8226.84  
HD-Glu+HD-LPS 2150.22 ± 1379.77  
Values are Mean ± SD (n=4). Control (serum-free media only), ND-Glu (normal dose 
glucose, 7 mM), HD-Glu (high dose glucose, 35 mM), LD-LPS (low dose LPS, 100 








95% Confidence Interval 




Control vs ND-Glu -163.81 1852.16 1524.53 1.00 
Control vs HD-Glu -11.65 1661.18 1637.88 1.00 
Control vs HD-Glu+LD-LPS -936.61 2841.33 968.09 1.00 
Control vs ND-Glu+HD-LPS -872.21 2776.92 1032.50 1.00 
Control vs HD-Glu+HD-LPS -2107.34 4012.05 202.63 0.015* 
ND-Glu vs HD-Glu -152.16 1241.94 1546.27 1.00 
ND-Glu vs HD-Glu+LD-LPS -772.80 2461.15 915.54 1.00 
ND-Glu vs ND-Glu+HD-LPS -708.40 2396.74 979.95 1.00 
ND-Glu Vs HD-Glu+HD-LPS -1943.53 3631.87 255.18 0.009* 
HD-Glu vs HD-Glu+LD-LPS -924.96 2574.49 724.56 1.00 
HD-Glu vs ND-Glu+LD-LPS -860.56 2510.09 788.97 1.00 
HD-Glu vs HD-Glu+HD-LPS -2095.69 3745.22 446.16 0.002* 




HD-Glu+LD-LPS vs  
HD-Glu+HD-LPS 
-1170.72 3075.43 733.99 1.00 
ND-Glu+HD-LPS vs  
HD-Glu+HD-LPS 
-1235.13 3139.84 669.58 1.00 
Control (serum-free media only), ND-Glu (normal dose glucose, 7 mM), HD-Glu (high 
dose glucose, 35 mM), LD-LPS (low dose LPS, 100 ng/mL), HD-LPS (high doses LPS, 
2µg/mL).* pvalue<0.05 (Bonferroni post hoc test)  
 
Table 3. The IL-6 level among groups 
Groups IL-6 (pg/mL) p value 
Control 55.16 ± 23.19 0.742 
ND-Glu 49.52 ± 29.28  
HD-Glu 43.37 ± 16.29  
ND-Glu+HD-LPS 53.06 ± 20.45  
HD-Glu+LD-LPS 52.08± 23.85  
HD-Glu+HD-LPS 59.66 ± 16.72  
Values are Mean ± SD (n=4). Control (serum-free media only), ND-Glu (normal dose 
glucose, 7 mM), HD-Glu (high dose glucose, 35 mM), LD-LPS (low dose LPS, 100 
ng/mL), HD-LPS (high doses LPS, 2µg/mL). 
* pvalue<0.05 (The one one way ANOVA test).  
 
 
Figure 1. Normal glucose 10 × 10. 
Figure 2. Normal glucose 10 × 40. 
Figure 3. High glucose 10 × 10. 
Figure 4. High glucose 10 × 40. 




